-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Innoviva, Maintains $46 Price Target

Benzinga·06/01/2026 10:58:51
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $46 price target.